Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and
Future Directions. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

The goal of assessing tumour response on imaging is to identify patients who are likely to
benefit—or not—from anticancer treatment, especially in relation to survival. The World …

Background Patients with intermediate-and advanced-stage hepatocellular carcinoma
(HCC) represent a highly heterogeneous patient collective with substantial differences in …

Purpose To compare currently available non–three-dimensional methods (Response
Evaluation Criteria in Solid Tumors [RECIST], European Association for Study of the Liver …

Hepatocellular carcinoma (HCC) is a malignant tumor of hepatocytes. It is a common
malignant tumor of the digestive system that often has initially hidden presentation followed …

Purpose To investigate whether whole-liver enhancing tumor burden [ETB] can serve as an
imaging biomarker and help predict survival better than World Health Organization (WHO) …

PURPOSE: To prospectively investigate whether Lipiodol can be used as a potential
imaging biomarker of tumor response after conventional transarterial chemoembolization …

Introduction To determine whether post-treatment magnetic resonance imaging (MRI)-based
texture analysis of liver metastases (LM) may be suited predicting therapy response to …

Purpose To evaluate the potential of imaging criteria in predicting overall survival of patients
with hepatocellular carcinoma (HCC) after a first transcatheter arterial yttrium-90 …

Abstract Background Overall Survival (OS) and Progression-Free Survival (PFS) analyses
are crucial metrics for evaluating the efficacy and impact of treatment. This study evaluated …